Results 201 to 210 of about 33,094 (239)

Effect of pregnancy on paroxysmal supraventricular tachycardia

The American Journal of Cardiology, 1993
more detailed study is undertaken. In the present study, 24% (6 of 25) of patients had either dual AV node pathways or multiple accessory pathways. In such cases, the initial use of an abbreviated protocol may actually prolong the procedure. One additional point merits consideration.
M, Tawam, J, Levine, M, Mendelson, J, Goldberger, A, Dyer, A, Kadish   +5 more
openaire   +2 more sources

PHENYLEPHRINE HYDROCHLORIDE IN PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA

Journal of the American Medical Association, 1955
Phenylephrine (Neo-Synephrine) hydrochloride was first suggested as an effective drug in the treatment of paroxysmal supraventricular tachycardia by Youmans and his group in 1947. Since this time others have mentioned its use and at the same time suggested that the drug was relatively innocuous in the absence of heart disease.
C K, DONEGAN, C V, TOWNSEND
openaire   +2 more sources

[Paroxysmal supraventricular tachycardia].

Anales espanoles de pediatria, 1991
We report 65 cases (1970-1989). They were processing in a data base program for cardiology records. A number of selected variables, were analysed by un statistical package. The results of 230 statistical tests between means, percentage and correlations, point out statistical value on prognosis forecast.
J, Ardura Fernández, J, Aldana Gómez, J, Andrés de Llano, M P, Aragón García   +3 more
openaire   +1 more source

Paroxysmal Supraventricular Tachycardia: Experience with Propafenone

Angiology, 1989
The authors studied the efficacy of intravenous (IV) (1.5-2 mg/kg) and oral propafenone (450 to 900 mg/day) in 16 patients with paroxysmal, sus tained, recurrent supraventricular tachycardia (SVT). In 5 patients IV propafenone was not given, because of intolerant SVT. Nine patients had Wolff-Parkinson-White syndrome.
V, Santinelli, M, De Paola, P, Turco, D, Smimmo, M, Chiariello   +4 more
openaire   +2 more sources

Mechanisms and Management of Paroxysmal Supraventricular Tachycardia

Cardiology in Review, 1999
Paroxysmal supraventricular tachycardia (PSVT) is defined as a regular rapid heart beat, which initiates and terminates suddenly. PSVT may have a variety of electrophysiologic mechanisms, including atrial tachycardia, atrioventricular (AV) nodal reentry, and tachycardia involving an accessory AV connection. Atrial tachycardia may be reentrant or may be
A, Kadish, R, Passman
openaire   +2 more sources

Verapamil for Control of Ventricular Rate in Paroxysmal Supraventricular Tachycardia and Atrial Fibrillation or Flutter: A Double-Blind Randomized Cross-Over Study

, 2020
H. Waxman, R. Myerburg, R. Appel, R. Sung   +3 more
semanticscholar   +1 more source

A Case of Paroxysmal Supraventricular Tachycardia

Pacing and Clinical Electrophysiology, 2004
Kristina, Wasmer, Michael, Ribbing, Gerold, Mönnig, Günter, Breithardt, Lars, Eckardt   +4 more
openaire   +2 more sources

PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA DURING ANESTHESIA

Survey of Anesthesiology, 1977
D H, Sprague, S D, Mandel
openaire   +2 more sources

Paroxysmal Supraventricular Tachycardias

Cardiac Electrophysiology Clinics, 2014
Mohammad Shenasa, Hossein Shenasa, Hamid Assadi, Mona Soleimanieh   +3 more
openaire   +1 more source

Emergency!: Paroxysmal Supraventricular TachyCardia

The American Journal of Nursing, 1997
openaire   +2 more sources